Litcius/Paper detail

Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials

Kyaw Zin Thein, Thura Win Htut, Somedeb Ball, Sriman Swarup, Anita Sultan, Thein Hlaing Oo

2020Breast Cancer Research and Treatment56 citationsDOI

Topics & Concepts

MedicineEndocrine systemMetastatic breast cancerBreast cancerOncologyCancerInternal medicineHormone receptorHormone therapyHormoneGynecologyAdvanced Breast Cancer TherapiesChemotherapy-induced cardiotoxicity and mitigationHER2/EGFR in Cancer Research
Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials | Litcius